Skip to main content
Erschienen in: Annals of Nuclear Medicine 8/2012

01.10.2012 | Original article

Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT

verfasst von: Yasushi Yamamoto, Masahisa Onoguchi, Masuo Haramoto, Nobuhiro Kodani, Akio Komatsu, Hajime Kitagaki, Kazuaki Tanabe

Erschienen in: Annals of Nuclear Medicine | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

The degree of myocardial technetium-99m-pyrophosphate (99mTc-PYP) accumulation in cardiac amyloidosis is conventionally evaluated by the PYP score. This method involves qualitative visual evaluation on two-dimensional images. Here, we performed three-dimensional quantitative analysis using software developed in our laboratory.

Methods

We performed dual myocardial imaging using thallium-201-chloride (201Tl-Cl) and 99mTc-PYP in cases of suspected cardiac amyloidosis and calculated the PYP accumulation rates of all myocardial pixels showing 99mTc-PYP accumulation. We defined this procedure as quantitative evaluation of the degree of 99mTc-PYP accumulation in the myocardium. Patients were divided into two groups with and without a diagnosis of cardiac amyloidosis, and we examined the PYP accumulation rates in both groups. In addition, we examined the PYP scores of the two groups by conventional qualitative evaluation.

Results

The PYP scores of the cardiac amyloidosis group were significantly higher than those of the other group. The PYP accumulation rates of the cardiac amyloidosis group were significantly higher than those of the other group. There were significant differences in the PYP accumulation rate and PYP score between the two groups. There was considered to be a threshold between the two groups in the case of the PYP accumulation rate.

Conclusions

When the threshold of the PYP score was defined as 3+ and that of the PYP accumulation rate as 41.5 %, the sensitivity of the PYP score and PYP accumulation rate was 84.6 %. However, the specificity of the PYP accumulation rate was higher than that of the PYP score. Quantitative evaluation by the PYP accumulation rate of the degree of 99mTc-PYP accumulation in the myocardium may be useful in the diagnosis of cardiac amyloidosis.
Literatur
2.
Zurück zum Zitat Tanaka J, Sawayama T, Hasegawa K. A symptomatography of organopathy and diagnostic procedure to be found in a generalized amyloidosis. Nihon Rinsho. 1991;49(4):841–6.PubMed Tanaka J, Sawayama T, Hasegawa K. A symptomatography of organopathy and diagnostic procedure to be found in a generalized amyloidosis. Nihon Rinsho. 1991;49(4):841–6.PubMed
3.
Zurück zum Zitat Hongo M, Misawa T, Yamada H, Hirayama J, Okubo S, Fujii T, et al. Diagnostic significance of Technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease a study with AL amyloidosis and familial amyloid polyneuropathy. Nihon Naika Gakkai Zasshi. 1986;75(1):1–8.PubMedCrossRef Hongo M, Misawa T, Yamada H, Hirayama J, Okubo S, Fujii T, et al. Diagnostic significance of Technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease a study with AL amyloidosis and familial amyloid polyneuropathy. Nihon Naika Gakkai Zasshi. 1986;75(1):1–8.PubMedCrossRef
4.
Zurück zum Zitat Nagatomo Y, Ikushima I, Matsuyama A, Nakagawa S, Koiwaya Y, Kenjiro T. Cardiac manifestations in patient with systemic amyloidosis. Shinzou. 1987;19(3):277–85. Nagatomo Y, Ikushima I, Matsuyama A, Nakagawa S, Koiwaya Y, Kenjiro T. Cardiac manifestations in patient with systemic amyloidosis. Shinzou. 1987;19(3):277–85.
5.
Zurück zum Zitat Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, et al. Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation. J Cardiogr. 1985;15(1):163–80.PubMed Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, et al. Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation. J Cardiogr. 1985;15(1):163–80.PubMed
6.
Zurück zum Zitat Imamoto T, Morita K, Onodera S, Tanazawa S, Amoh K, Ishikawa Y, et al. Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy—a case report. Kaku Igaku. 1988;25(10):1117–23.PubMed Imamoto T, Morita K, Onodera S, Tanazawa S, Amoh K, Ishikawa Y, et al. Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy—a case report. Kaku Igaku. 1988;25(10):1117–23.PubMed
7.
Zurück zum Zitat Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Hongou M, et al. Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis. Kaku Igaku. 1997;34(11):1033–8.PubMed Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Hongou M, et al. Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis. Kaku Igaku. 1997;34(11):1033–8.PubMed
8.
Zurück zum Zitat Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol. 1983;51(5):826–30.PubMedCrossRef Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol. 1983;51(5):826–30.PubMedCrossRef
9.
Zurück zum Zitat Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol. 1984;54(8):1150–1.PubMedCrossRef Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol. 1984;54(8):1150–1.PubMedCrossRef
10.
Zurück zum Zitat Takezaki M, Ishida Y, Morozumi R, Tani A, Satou H, Hori M, et al. Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate(Tc-99m PYP) myocardial scintigraphy in 2 case with familial amyloid polyneuropathy and 1 case with secondary amyloidosis. Kaku Igaku. 1989;26(12):1537–43.PubMed Takezaki M, Ishida Y, Morozumi R, Tani A, Satou H, Hori M, et al. Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate(Tc-99m PYP) myocardial scintigraphy in 2 case with familial amyloid polyneuropathy and 1 case with secondary amyloidosis. Kaku Igaku. 1989;26(12):1537–43.PubMed
11.
Zurück zum Zitat Morozumi R, Hori M, Kamada T, Uehara T, Kusuoka H, Nishimura T, et al. Usefulness of technetium-99m pyrophosphoric acid scintigraphy in cardiac amyloidosis diagnosis. Prog Treat Cardiovasc Dis. 1995;14(1):28–32. Morozumi R, Hori M, Kamada T, Uehara T, Kusuoka H, Nishimura T, et al. Usefulness of technetium-99m pyrophosphoric acid scintigraphy in cardiac amyloidosis diagnosis. Prog Treat Cardiovasc Dis. 1995;14(1):28–32.
Metadaten
Titel
Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT
verfasst von
Yasushi Yamamoto
Masahisa Onoguchi
Masuo Haramoto
Nobuhiro Kodani
Akio Komatsu
Hajime Kitagaki
Kazuaki Tanabe
Publikationsdatum
01.10.2012
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 8/2012
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-012-0627-y

Weitere Artikel der Ausgabe 8/2012

Annals of Nuclear Medicine 8/2012 Zur Ausgabe